TR200904341A2 - Stable pharmaceutical compositions containing rosuvastatin calcium. - Google Patents

Stable pharmaceutical compositions containing rosuvastatin calcium.

Info

Publication number
TR200904341A2
TR200904341A2 TR2009/04341A TR200904341A TR200904341A2 TR 200904341 A2 TR200904341 A2 TR 200904341A2 TR 2009/04341 A TR2009/04341 A TR 2009/04341A TR 200904341 A TR200904341 A TR 200904341A TR 200904341 A2 TR200904341 A2 TR 200904341A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
rosuvastatin calcium
compositions containing
stable pharmaceutical
containing rosuvastatin
Prior art date
Application number
TR2009/04341A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/04341A priority Critical patent/TR200904341A2/en
Priority to PCT/TR2010/000103 priority patent/WO2010140992A1/en
Publication of TR200904341A2 publication Critical patent/TR200904341A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, en az % 60 oranında laktoz içermek suretiyle kararlı hale gelen, oral rosuvastatin kalsiyum fannasötik bileşimine, bu bileşimin hazırlanması için yöntemlere ve hazırlanan bileşimin tedavi amaçlı kullanımına dairdir.The present invention relates to an oral rosuvastatin calcium pharmaceutical composition which is stabilized by containing at least 60% lactose, methods for the preparation of this composition, and therapeutic use of the prepared composition.

TR2009/04341A 2009-06-03 2009-06-03 Stable pharmaceutical compositions containing rosuvastatin calcium. TR200904341A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (en) 2009-06-03 2009-06-03 Stable pharmaceutical compositions containing rosuvastatin calcium.
PCT/TR2010/000103 WO2010140992A1 (en) 2009-06-03 2010-05-27 Stable pharmaceutical compositions containing rosuvastatin calcium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/04341A TR200904341A2 (en) 2009-06-03 2009-06-03 Stable pharmaceutical compositions containing rosuvastatin calcium.

Publications (1)

Publication Number Publication Date
TR200904341A2 true TR200904341A2 (en) 2010-12-21

Family

ID=43020424

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/04341A TR200904341A2 (en) 2009-06-03 2009-06-03 Stable pharmaceutical compositions containing rosuvastatin calcium.

Country Status (2)

Country Link
TR (1) TR200904341A2 (en)
WO (1) WO2010140992A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101302306B1 (en) 2011-01-26 2013-09-03 씨제이제일제당 (주) complex for improving, alleviating, treating or preventing of hyperlipidemia
CN104434826B (en) * 2014-11-08 2018-03-20 鲁南贝特制药有限公司 A kind of Rosuvastatin calcium dispersible tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (en) 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
HU217629B (en) 1991-12-12 2000-03-28 Novartis Ag. Process for producing stabilized pharmaceutical compositions comprising fluvastatin
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
HU227610B1 (en) 2006-09-18 2011-09-28 Richter Gedeon Nyrt Pharmaceutical compositions containing rosuvastatin potassium
WO2008062476A2 (en) * 2006-10-31 2008-05-29 Glenmark Pharmaceutical Limited Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
GB0713707D0 (en) * 2007-07-13 2007-08-22 Generics Uk Ltd Stable compositions
CA2637977A1 (en) * 2008-07-15 2010-01-15 Pharmascience Inc. Dosage form containing a statin
PL386051A1 (en) * 2008-09-09 2010-03-15 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Stable, oral compound pharmaceutical containing pharmaceutically permissible content of [(E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl] (3R,5S)-3,5-dihydroxy-hept-6-enoate acid salt
TR200902077A2 (en) * 2009-03-17 2010-01-21 Sanovel İlaç San.Veti̇c.A.Ş. Stable rosuvastatin compositions

Also Published As

Publication number Publication date
WO2010140992A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
EA200970581A1 (en) CRISTAL TREATMENT BASIS BACKGROUND
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
TW200621313A (en) Pharmaceutical compositions
MX2013001677A (en) Stable formulations of linaclotide.
EA201001680A1 (en) COMPOUNDS OF BENZOLSULPHONAMIDTIAOSOL AND OXAZOL
MX2009010977A (en) Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring.
MX2019012939A (en) Linaclotide-containing formulations for oral administration.
EA200971115A1 (en) NEW HIV REVERSE TRANSCRIPTASE INHIBITORS
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
EA201001639A1 (en) COMPOSITIONS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
EA201001682A1 (en) Derivatives of phenyl and benzodioxynyl-substituted indazols
EA201190017A1 (en) AMINO ETHER DERIVATIVES OF ALKALOIDS AND THEIR MEDICAL COMPOSITIONS
GB2511685A (en) Muscarinic m1 receptor agonists
EA200970065A1 (en) DERIVATIVES OF PIPERAZINIL, INTENDED FOR THE TREATMENT OF DISEASES MEDIATED BY GPR38
UA112055C2 (en) SALTS 4- [2 - [[5-METHYL-1- (2-NAPHTHALINYL) -1H-PYRAZOL-3-yl] OXY] ETHYL] MORPHOLINE
MA32776B1 (en) INHIBITORS OF AKT AND P70 S6 KINASE
TW200745122A (en) New compounds I
EA201300034A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IMATINIB OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, AND WAYS TO OBTAIN THEM
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
EP2528578A4 (en) Dental composition comprising a calcium source
EA201590364A1 (en) APPLICATION OF AIRWAY PERSON, HIS SALTS AND CRYSTALLINE FORMS AND COMPOSITIONS, ITS CONTAINING, FOR THE TREATMENT OF ZUD
EA201000434A1 (en) SOKRISTALY Pyrimethanilus and Dithianon
MA32479B1 (en) Compounds new active as muscarinic receptor antagonists
EA200602049A1 (en) PROCEDURES OF STEROIDS WITH ANDROGENIC ACTION